Can’t see the audio player? Click here to listen.
Can a healthcare company make enough people angry about its billing practices that its business is hurting? For a genetic testing company, maybe.
An “arms and legs” listener was given a test that has become routine in early pregnancy: a non-invasive prenatal test. It should be $99. But then – after she took the test – it became $250. When she asked questions, she was told it could go up to $800 if she didn’t pay sooner. Patients inquired about testing companies and found that many had experienced what she called “genetic testing bait and switch.”
And importantly – she wasn’t the only one who noticed. When some on Wall Street and a reporter for the New York Times started hearing about the bills, the company found itself in a bind.
“One arm and one leg” is a collaboration- Production by KHN and Public Road Productions.
To stay connected with “An Arm and a Leg”, subscribe to the newsletter. You can also follow the show on Facebook and Twitter. If you have a story about the healthcare system, the producers would love to hear from you.
We encourage organizations to republish our content for free. Here are our requirements:
You must identify us as the original publisher and include a hyperlink to our khn.org site . If possible, include the original author and “Kaiser Health News” in the byline. Please keep the hyperlink in the story.
It is important to note that not all content on khn.org can be republished. If a story is marked “All Rights Reserved”, we cannot grant permission to republish the item.
Is there a problem? Let us know at [email protected]